SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 108.94 |
| Enterprise Value ($M) | 180.78 |
| Book Value ($M) | -102.20 |
| Book Value / Share | -3.25 |
| Price / Book | -1.07 |
| NCAV ($M) | -156.44 |
| NCAV / Share | -4.97 |
| Price / NCAV | -0.70 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.36 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.03 |
| Current Ratio | 1.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 68.13 |
| Assets | 122.37 |
| Liabilities | 224.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 197.19 |
| Operating Income | 31.61 |
| Net Income | 3.16 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 45.24 |
| Cash from Investing | -18.80 |
| Cash from Financing | -76.08 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Roystone Capital Management LP | 12.00 | 27.89 | |
| 13G/A | Bandera Partners LLC | 7.50 | 32.90 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 24,662 | 108,467 | 22.74 | |
| 19,022 | 70,592 | 26.95 | |
| 33,838 | 159,154 | 21.26 | |
| 40,103 | 301,817 | 13.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AXSM – Axsome Therapeutics, Inc. | BCAB – BioAtla, Inc. |
| BHST – BioHarvest Sciences Inc. | CADL – Candel Therapeutics, Inc. |
| CARM – Carisma Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io